News
Zacks Investment Research on MSN11h
Investors Heavily Search Novavax, Inc. (NVAX): Here is What You Need to Know
Novavax (NVAX) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some ...
Under Robert F. Kennedy Jr., federal officials may withdraw an endorsement for the vaccine in younger children.
A Food and Drug Administration official who stepped down less than two weeks ago is getting his job back as the agency’s top ...
Novavax on Wednesday raised its full-year revenue forecast as it received a $175 million milestone payment from Sanofi ...
Novavax beats Q2 expectations with $239 million in revenue, lifts 2025 guidance, and reports profit as costs decline and ...
Novavax raised its full-year adjusted revenue forecast on Wednesday, banking on higher sales tied to its vaccine supply ...
7d
Novavax stock surges as HHS pulls mRNA vaccine funding, opening doors for alternative technologies
The federal government’s move to pull hundreds of millions of dollars in funding for mRNA vaccines could be a shot in the arm ...
Why Novavax’s vaccine was authorized 2 years into the pandemic Novavax CEO Stanley Erck discusses his company’s COVID-19 vaccine, which was authorized by the FDA this week.
Topline Shares for Novavax swelled by more than 130% Friday morning, after the biotech firm announced a $1.4 billion deal with Sanofi to commercialize its Covid vaccine and develop a new ...
Novavax stock has plummeted from $290 a share in February 2021 to around $50 recently. The FDA finally appears poised to authorize the company's vaccine, however.
Q2 2025 Earnings Call Transcript August 6, 2025 Novavax, Inc. beats earnings expectations. Reported EPS is $0.601, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results